chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Headache; fever of 101; Chills; Strange dreams; Insomnia; several bowel movements; hemorrhoids; Fatigue; all over body pain; Dizziness; tightness in chest; Difficulty breathing; muscle pain in injected arm; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) via an unspecified route of administration in the right arm on 15May2021 at 11:30 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. Concomitant medications included gabapentin (MANUFACTURER UNKNOWN), baclofen (MANUFACTURER UNKNOWN), zolpidem tartrate (AMBIEN), omeprazole (MANUFACTURER UNKNOWN) and ethinylestradiol, ferrous fumarate, norethisterone acetate (LO LOESTRIN FE). The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) via an unspecified route of administration in the right arm on 24Apr2021 at 11:30 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 15May2021 at 14:30, the patient experienced headache, fever of 101, chills, strange dreams, insomnia, several bowel movements which caused haemorrhoids, fatigue, all over body pain, dizziness, fatigue, tightness in chest, difficulty breathing and muscle pain in injected arm. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events headache, fever of 101, chills, strange dreams, insomnia, several bowel movements, hemorrhoids, fatigue, all over body pain, dizziness, tightness in chest, difficulty breathing and muscle pain in injected arm were recovering at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
STUFFY NOSE; STARTED TO SWEAT; FEVER; HEADACHE; This spontaneous report received from a patient concerned a 73 year old female.  The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported.  The patient received vaccination with covid-19 vaccine ad26.cov2.s (dose number in series 1) (suspension for injection, route of admin not reported, and batch number: 1808978) dose was not reported, administered on 29-MAR-2021 for prophylactic vaccination.   On an unspecified date following vaccination with covid-19 vaccine ad26.cov2.s (dose number in series 1), the patient experienced tired.   The action taken with covid-19 vaccine ad26.cov2.s was not applicable.  The patient received booster dose of covid-19 vaccine ad26.cov2.s (dose number in series 2) (suspension for injection, route of admin not reported, batch number: 1855194 expiry: UNKNOWN) dose was not reported, administered on 08-NOV-2021 for prophylactic vaccination. No concomitant medications were reported.   On 09-NOV-2021, the patient experienced stuffy nose, started to sweat, fever and headache.(dose number in series 2)   Treatment medications (dates unspecified) included: chlorphenamine maleate/paracetamol/pseudoephedrine hydrochloride.  The action taken with covid-19 vaccine ad26.cov2.s was not applicable.  The patient recovered from fever, and headache, had not recovered from stuffy nose, and the outcome of started to sweat was not reported.  This report was non-serious.  This case, involving the same patient is linked to 20211127601 (Dose series in number 1).
Day of shot, sick to stomach 4 days p/rash, fever, sun or light hurt eyes, loss of appetite, & glands were large;
Breakthrough case admission after three vaccines Moderna 3/31/21 Lot# 002B21A;  Moderna 4/29/21 Lot# 017C21A;  Moderna 11/10/21 Lot# 032F21A
Moderna COVID?19 Vaccine EUA  fever, pain, edema and swollen lymph node
Less than 24 hrs after immunization Lt upper arm became swollen, erythematous and warm compared to other areas of skin. 72 hrs post immunization swelling expanded to forearm and shoulder. Treated with antihistamines.
Information has been received from an inventory manager concerning a female nurse who on 03-NOV-2008 was vaccinated with PNEUMOVAX 23. On 03-NOV-2008, the nurse developed a reaction. The nurse was seen at her physician's office in the morning of 04-NOV-2008. Additional information was received from a pharmacist concerning the nurse who on 03-NOV-2008, at 13:00, was vaccinated with PNEUMOVAX 23 (lot# 659199/1541U). It was unknown if the patient has received PNEUMOVAX 23 in the past. It was reported that influenza virus vaccine (unspecified) was given on 21-OCT-2008, 2 weeks ago. On 03-NOV-2008, within the hour of vaccination (by 14:00), the nurse experienced an "allergic reaction" at the injection site. Her left arm was swollen, burning and painful. The patient saw a physician at a clinic for follow-up but pharmacist did not know the physician's name. Additional information has been requested.
This spontaneous report was received from a pharmacist refers to a 58 year old female patient. The patient's concurrent conditions and medical history were not reported. On 07-MAY-2015, the patient was vaccinated with ZOSTAVAX (lot #, expiration date, dose and anatomical location were not reported) via subcutaneous route for the prevention of shingles. Concomitant therapies included atorvastatin, PLETAL and CHANTIX. On the same day, the patient developed tearing, crusting and inflammation in both eyes. The patient sought medical attention. The patient did not received any treatment for the adverse events. The outcome of the events was reported as not recovered. Causality assessment was not reported. No product complaint involved.
Itchy maculopapular rash 9 days after receiving smallpox vaccine.
bodyaches, severe w/in 16 hrs of vax; induration @ site of inject 36-48 hrs measuring 8cm x 8cm; tx Keflex x 10 days & heat to site; to ER; devel red swollen painful deltoid region arm aches, pos bodyaches, infected inject site, tx w/ATB
Patient's mother stated that patient began complaining of an itchy rash around his eyes, lip, and genitals. Patient reported that the itching began around 1830 - 1900 the same day he was vaccinated. Patient's mother states that there is no rash on his arms, where he received the immunizations. She states that it "looks like poison ivy," and reports that they went to a lake house two days before coming in for vaccinations. Patient's mother reports that patient has had no difficulty breathing or swallowing, has had no difficultly walking, and has had no impairment to his vision. Patient's mother reported that she gave the patient Benadryl, which helped with the itching. This nurse has attempted to contact patient's mother to follow up on the patient's condition, but has been unsuccessful.  This nurse is unsure if patient's mother ended up taking the patient to a doctor's office for treatment/follow-up.
sore arm; A spontaneous report was received from  a HCP concerning a 66 years old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events sore arm.  the patient's medical history is provided as the patient have rheumatoid arthritis. relevant concomitant medications are also provided. The patient having Methotrexate Enbrel for rheumatoid arthritis.  On 28-JAN-2021,prior to the onset of the events, the patient received their second dose of two planned doses of mRNA-1273(Batch number unknown) for prophylaxis of COVID-19 infection.  On 29-JNA-2021,same date of vaccination the patient experienced the event of sore arm..  Laboratory details are not provided.  Treatment details are not provided.  Action taken with mRNA-1273 in response to the events was not reported.  Outcome of the event in 28-JAN-2021 remain unknown at the time of this report.  Based on MSA comment, sore arm change to vaccination site pain and listed in all RSIs.
It feels like I have the flu. I have a fever of 100.3. I have a headache, nausea, chills, and every joint and muscle in my body hurts to articulate. This started at around midnight in my  bed while I was asleep the same day I got my shot. I'm autistic, and I?m in a therapy program with other autistic 20 year olds and those who also got the shot were likewise experiencing the same symptoms as me. I have yet to recover.
temp inc 9 days post vax to 101 & to 103 day ten no other sx x/draining ears; OM dx on day 10 started on ATB;
Erythema of lt deltoid area approx 3 x 5 began @ site of inject 1 wk p/inject;
Patient waited out 15 required minutes, plus another 15 just incase due to the bee sting issue. Patient was fine the duration of the day The next morning patient woke up not feeling well, had extreme fatigue and was having difficulty breathing Patients daughter put her in the car and headed to the hospital, on route to the hospital the patient started to  become unconscious and was not breathing a passer by had an epinephrine pen and injected the patient into the thigh. Patient immediately came out of the previous state. The recuse squad was called and they brought patient to the Emergency room. The patient was monitored and ultimately discharged with no further issues.
This spontaneous report as received from a pharmacy technician concerning a currently 49 years old patient. Gender was not reported. Medical history and concurrent conditions were not reported. On 25-APR-2014, the patient was vaccinated with VARIVAX (Merck) lot #J003700; expiration date: 27-MAR-2015, (dose, strength and route were not reported). Secondary and concomitant therapies were not reported. Patient was vaccinated with VARIVAX (Merck) that was exposed to 43.1 degrees F for 29 hours on 03-MAR-2014. This is one of several reports from the same reporter. Additional information has been requested.
Pt. said pain in her upper inner arm started about a week after her vaccine.  She said it has been getting worse and it now radiates down her arm to the tip of her middle finger.  She also said that it sometimes radiates up into her neck towards her jaw.
Vaccine exposure via breast milk; Fever and diarrhea in breastfeeding toddler; Fever and diarrhea in breastfeeding toddler; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the parent.  A 13 month-old patient was exposed to bnt162b2 (BNT162B2), transmammary, administration date 21Sep2021 15:30 (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: EXPOSURE VIA BREAST MILK (non-serious) with onset 22Sep2021, outcome "unknown", described as "Vaccine exposure via breast milk"; DIARRHOEA (non-serious), PYREXIA (non-serious) all with onset 22Sep2021, outcome "unknown" and all described as "Fever and diarrhea in breastfeeding toddler". Therapeutic measures were not taken as a result of exposure via breast milk, diarrhoea, pyrexia.  Additional information: Event Experienced: Vaccine exposure via breast milk (Vaccine exposure via breast milk), (Drug use in unapproved age group); Fever and diarrhea in breastfeeding toddler (Fever), (Diarrhea). Admission to hospital was not involved and notreceived any treatment as a result of adverse events. It was unknown whether patient was still experiencing events. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine and not received any other medications the patient received within 2 weeks of vaccination. Prior to vaccination, was the patient was not diagnosed with COVID-19. Since the vaccination, has the patient has not been tested for COVID-19.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
April 16: Headache. Stomachache.  Sore arm. Weak & dizzy. Temperature ranged from 99.8 to 101.2 all day.  April 17: Very sore arm. Headache. Stomachache. Weak&dizzy. Temperature ranged from 99.5 to 101 all day. April 18: Arm less sore. Temperature ranged from 98 to 98.8. Upper lip Very Swollen. No headache just some dizziness.
I got all over on me  an allergic skin reaction redness burning, very itchy and painful sensation
Vaccine was administered into the left arm.  Patient was instructed to remain near pharmacy for 10 minutes after vaccination.  Around 5 minutes later, I was notified that patient felt she was having a reaction.  Patient stated pain started as back pain, then head pain and then it was chest pain.  I took patient's blood pressure and it was 169/85, which the patient stated was higher than hers normally ran.  She started to feel better, she stood up to move to the consultation room and experienced dizziness.  The injection site bled but there was no swelling/redness present.  I called the primary care physician and they advised her to go the ER since she has a previous history of heart attack.  She had a friend take her to the ER.  I spoke with her that afternoon and they were going to keep her overnight for observation.  She stated they had told her it was a reaction to the vaccine.  All tests they ran came back ok.  Spoke with patient the following day and she had been discharged and was feeling better.
patient reports that she had the vaccine on 03/16/2021.  she states that some time in April (specific date not given) she went to the chiropractor and had a lot of bruises on her body. she denied any trauma and believed it was caused by the vaccine. she reported to me at a recent office visit. at the time she stated she was not getting any new lesions. she did admit to some use of NSAIDs.  There is also a family history of bruising in her mother.  She believes it started as a result of the vaccine though.
flu like symptoms; This case was reported by a pharmacist via call center representative and described the occurrence of influenza-like symptoms in a 62-year-old female patient who received Herpes zoster (Shingrix) (batch number KC9C4, expiry date 30th March 2020) for prophylaxis.   On 20th May 2019, the patient received the 1st dose of Shingrix. On 20th May 2019, less than a day after receiving Shingrix, the patient experienced influenza-like symptoms. On an unknown date, the outcome of the influenza-like symptoms was recovered/resolved.   It was unknown if the reporter considered the influenza-like symptoms to be related to Shingrix.  Additional details were provided as follows: The patient received dose of Shingrix in the left arm. The patient experienced influenza like symptoms, after vaccination with dose of Shingrix. This case was 1 of the 2 linked cases.
Patient received 5-11 year dose instead of 6 month- 4 year dose;  no reaction noted; will receive next dose on schedule
This spontaneous report was received from a certified medical assistant and refers to a patient of unknown age and gender. The patient's concurrent conditions, medical histories and concomitant medications were not reported. On 01-MAR-2016, the patient received improperly stored VARIVAX lot # L035128, expiration date: 14-SEP-2017 (exact dose, route of administration and anatomical location were not provided). There were no adverse effects reported. Administered dose of vaccine experienced the temperature excursion of 9 degrees Fahrenheit for 1 hour. There was no previous temperature excursion. This is one the several reports from the same reporter. Additional information has been requested.
After getting the booster I start feeling bad, I had a very bad cough. I went to the hospital and found out I had ammonia.
I am a 30 year old healthy person, I weigh 172lbs, I am 5'10", I work, resting heart rate is in the 60s, blood pressure usually around 115/70, never had a reaction to any other vaccine,   12/31- Vaccine at 0919; 2100 felt like I had the flue suddenly (body aches); 2130 my heart was beating so fast I checked my watch, my heart rate was 83, over the next few minutes my heart rate increased to 140,  you could see my heart beating out of my chest, over the next hour my heart rate sustained in the 120s and 130s, then slowly came down to 100s and then to 80s by midnight.  1/1 I was lethargic with a headache and body aches throughout the day, treated with 800mg ibuprofen twice throughout the day; 2045 I noticed a rash on both sides of my neck, chest, abdomen, top of shoulders, sides of abdomen and inside my legs; I took 25mg Benadryl, no change in rash 1/2 I took Claritin at 1000 by 1400 rash was almost gone.
Had JEV in his assigned clinic. Thirty minutes later he developed a "lump" on the roof of his mouth.
Rash on face and neck. Red flat like bumps that itch. Did a detox bath with apple cider vinegar, bentonite clay, and had her drink alkaline water.
received 2nd covid19 vaccine around 8:10am, by around 5pm same day started with chills, headache and by early next morning had a fever of 100.1 F,  dizziness.  Sunday around mid afternoon fever broke and still had headache.  Tylenol and Aleve were alternated.  Headache finally was minimal on Monday.
A report has been received from a Health Professional concerning a 15 year old, Male subject, who had been receiving Nasal FLUMIST (INTRANASAL), HALF DOSE. FLUMIST (FLUMIST) started on an unknown date. The 15 YEAR OLD RECEIVED ONLY A HALF DOSE OF FLUMIST which started on 10-Oct-2014. The outcome of the event of 15 YEAR OLD RECEIVED ONLY A HALF DOSE OF FLUMIST is unknown. The report was considered to be non-serious.
numbness in the shin area on right leg; pain in right knee; difficulty walking up and down stairs; This case was reported by a consumer via call center representative and described the occurrence of numbness in leg in a 59-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 18th January 2023, the patient received the 1st dose of Shingrix. In January 2023, unknown after receiving Shingrix, the patient experienced walking difficulty. On 21st January 2023, the patient experienced numbness in leg and knee pain. On an unknown date, the outcome of the numbness in leg, knee pain and walking difficulty were not recovered/not resolved.   It was unknown if the reporter considered the numbness in leg, knee pain and walking difficulty to be related to Shingrix.     Additional Information: GSK Receipt date: 23-Jan-2023 Reporter's Comment: The patient self-reported this case. The patient received Shingrix on left arm. The patient stated that he felt pain in his right knee and numbness in the shin area on his right leg. He now had difficulty walking up and down stairs. Symptoms had not yet resolved. The patient requested, if possible, that Safety contact him to let him know if other patients had experienced knee pain with Shingrix. The reporter consented to follow-up.
Pt called at 10:20 to Immunization clinic and stated she had broken out in hives and  her throat was swelling up, pt was then instructed to call 112 (ambulance)and go to the ER. Pt Appeared in Clinic 10 minutes later and was rushed to treatment room. Pt had hives all over body and was barely able to speak, pt stated that throat was itchy and closing up. Pt was seen by porvider and administered 02, epi, IV, bendryl and solumedrol and transported to ER.
Patients received an expired dose; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patients received an expired dose) in a 39-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patients received an expired dose). On 09-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Patients received an expired dose) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant information was reported. No treatment information was reported. On 08-Nov-2021, the vial was initially stored in the refrigerator.
10/06/2017 - Charted by NP Local reaction to influenza vaccine, initial encounter It is interesting that with the timing, I would expect that this reaction would be closer to the injection site. However, the localized erythema noted is more distal to the injection site.  I am not 100% convinced that this is truly a reaction to the influenza vaccine and something much more coincidental, but just in case, when she obtains her influenza vaccine next year, she should stay in the clinic for 15-20 minutes post vaccine to make sure she does not have any kind of reaction. If she has a more severe reaction next year, then he we may have to list influenza vaccine as an allergy. In the meantime, patient is to ice the area for 10-15 minutes every 2-3 hours regularly for the next 24-48 hours. She should continue taking acetaminophen and should also take meclizine a bit more regularly if she is able. If she is not needing meclizine for dizziness, then she may take over-the-counter loratadine 1 daily as an antihistamine to help curb any type of reaction. Reviewed signs and symptoms of worsening conditions such as swelling, worsening pain, or worsening redness. The redness may get worse before it gets better, but it should improve or resolve within the next week. Patient verbalized understanding of instructions and plan.
42hr s/p vaccines pt awakened w/hives & swollen lips;pt was seen by MD given DPH & pred;problem resolved 99% in 2hr;
Information has been received from a physician concerning a female patient in her 20's who on an unspecified dates was vaccinated with the 3 doses of GARDASIL (Lot # and route not reported). The physician reported that the patient completed the GARDASIL series but on an unspecified date she contracted high risk HPV. The physician also stated that the patient was not sexually active prior to receiving GARDASIL and then had only one partner after completing the series. At the time of the report the outcome of the patient was not reported. It was unknown if the patient sought medical attention. Additional information has been requested.
Patient hospitalized within 6 weeks of receiving COVID vaccination to have induction of labor. Per doctor's notes 4/18/21: She delivered by SVD without complication and was stable post delivery.  She had a 7# 1oz male.  She had an uncomplicated postpartum course, advancing regular diet.
Vertigo and fever occurred 24 hours after 2nd vaccination.  Presented to ED and hospitalized for small right cerebellar stroke.